
    
      The investigators are undertaking a parallel group, multicenter, randomized controlled trial
      of 132 adults with ITP in China. Patients were randomized to ATRA+ high-dose dexamethasone
      and high-dose dexamethasone monotherapy group. Platelet count, bleeding and other symptoms
      were evaluated before and after treatment. Adverse events are also recorded throughout the
      study.
    
  